ArticleCureus2026

Clinical Safety Profile of Bruton's Tyrosine Kinase (BTK) Inhibitors in Chronic Lymphocytic Leukaemia: A Real-World Ambispective Study From India.

Arya Pradhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.